MedTrace Logo

A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers

NCT00648674 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-08-19

No results posted yet for this study

Summary

Single site clinical study utilizing the novel technology of microarrays to identify and characterize the molecular mechanisms through which Apligraf promotes healing of venous leg ulcers.

Conditions

  • Varicose Ulcer

Interventions

DEVICE

Apligraf

Applied at Day 0, possible re-application at Week 6

Sponsors & Collaborators

  • Organogenesis

    lead INDUSTRY

Principal Investigators

  • Damien Bates, MD, PhD, FRACS (Plast.) · Organogenesis Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-03-31
Completion
2010-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00648674 on ClinicalTrials.gov